Zymergi LogoCart

483 Document: Aspire Pharmaceuticals, Inc., Jul 14, 2023

FDANews 483 Aspire Pharmaceuticals, Inc. Jul 14 2023 top
Robin P. Mathew FDA Investigator Charlotte P. Chang FDA Investigator Annet R. Rajan FDA Investigator Jessica M. Monteiro FDA Investigator

On Jul 14, 2023, the FDA inspected Aspire Pharmaceuticals, Inc.'s Somerset site. Explore the inspectional observations.